News

Filter

Current filters:

Alli

1 to 9 of 23 results

US FDA warns of rare cases of liver injury with use of obesity drugs Xenical and Alli

27-05-2010

The US Food and Drug Administration yesterday advised consumers and health care professionals about potential…

AlliGlaxoSmithKlineMetabolicsNorth AmericaorlistatOrlistat 60 mgRegulationRocheXenical

FDA warns US consumers about counterfeit weight-loss drug Alli

19-01-2010

The US Food and Drug Administration yesterday issued a warning to consumers about a counterfeit and potentially…

AlliGlaxoSmithKlineGSKMetabolicsNorth AmericaOrlistat 60 mgPharmaceuticalRegulation

Rise in weight-loss drugs prescribed in the UK to combat childhood obesity

03-09-2009

Thousands of children and adolescents are using anti-obesity drugs that in the UK are only licensed for…

AlliEuropeGlaxoSmithKlineGSKMetabolicsorlistatOrlistat 60 mgPharmaceuticalRocheXenical

US FDA reviewing Roche weight loss drug Xenical and OTC alli from GlaxoSmithKline

25-08-2009

The US Food and Drug Administration says that it is reviewing adverse event reports of liver injury in…

AlliGlaxoSmithKlineGSKMetabolicsNorth AmericaorlistatOrlistat 60 mgPharmaceuticalRocheXenical

UK's GSK launches blog, but only for US residents

29-05-2009

The UK-based drug major GlaxoSmithKline has launched a blog titled More Than Medicine (which is also…

AlliGlaxoSmithKlineGSKJohnson & JohnsonOrlistat 60 mg

UK pharmacists alerted on orlistat dispensing

28-04-2009

Following the recent launch in the UK of an over-the-counter versions of Roche's obesity drug orlistat…

AlliGlaxoSmithKlineGSKOrlistat 60 mgRoche

1 to 9 of 23 results

COMPANY SPOTLIGHT

Menarini

Back to top